Showing 321-330 of 1835 results for "".
Immune-Mediated Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immune-mediated-cerebellar-ataxias/31708/Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.Inclusive Research for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inclusive-research-for-multiple-sclerosis/31755/Inclusive research improves quality of scientific data, facilitates discovery of safety and efficacy, and assists in identifying population-specific differences.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/movement-disorders/case-report-hemiparkinsonism-in-a-patient-with-multiple-sclerosis/31527/In this case, there was a causal relationship between comorbid diseases.Migraine Acute Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-acute-therapies/31513/Acute treatment of migraine improves daily function and reduces associated disability and risk of transformation to chronic migraine.Migraine Preventive Therapies in Development
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies-in-development/31512/The field of headache medicine is full of promise with more migraine-specific preventive therapies in development.- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0307-movedisorders-pdf/31203/Accurate assessment of movement disorders is crucial for clinicians to quantify their impact on patients’ quality of life and monitor disease progression. Practical Neurology’s recent article delves into various validated rating scales tailored for specific neurological conditions, enhancing objecti
Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Genetic Mechanisms of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-mechanisms-of-epilepsy/31588/Understanding gene and protein functions can sometimes guide diagnosis and treatment.Diagnostic & Treatment Delay in Temporal Lobe Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-treatment-delay-in-temporal-lobe-epilepsy/31835/The average 20-year delay of referral to epilepsy centers can be improved.